Further update re Paraytec AD Scanner project

Reach - a non-regulatory announcement

 4 August 2021

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further update re Paraytec AD Scanner project

Further to the announcement on 14 June 2021, Braveheart Investment Group plc (AIM: BRH), regarding Paraytec's work with partners in the field of Alzheimer's disease (AD) detection and also the Covid-19 detection project.

Prototype instruments were shipped to project partners in early July 2021 and sample testing has commenced. The initial results from Vrije University Medical Centre Amsterdam (VUMC) using AD patient samples were inconclusive. The cause and implications of these initial results are not yet known. Further testing is needed and although the funded project will end at the end of this month, Paraytec's partners have indicated that they will continue the testing thereafter.  A further update is expected by the end of September 2021.

Paraytec's work to develop an instrument for the detection of COVID-19 is progressing as planned and a corporate finance specialist has been engaged to market the technology to potential partners or acquirers.

We anticipate releasing the next update for both the COVID-19 and AD scanner projects will be around the end of September 2021.

For further information:

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain.  Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.